FDAnews
www.fdanews.com/articles/114736-roche-plans-dollar-bonds-for-genentech-offer

Roche Plans Dollar Bonds for Genentech Offer

February 18, 2009
Swiss drugmaker Roche Holding plans a six-part U.S. dollar global bond to help finance its $42 billion hostile offer for U.S. biotechnology company Genentech Inc, an official at a bank managing the sale said.
CNBC